ARQT

ARCUTIS BIOTHERAPEUTICS INC

Investor Moves

NameValueActionChangePriceLast Price
Ron BaronBaron Capital
$25M1.1M shares
AddQ1 2026
$11M
$23.60
$27.74
Ken GriffinCitadel Advisors
$2M98.2k shares
TrimQ1 2026
$6M
$23.60
$27.74
Paul Tudor Jones IITudor Investment
$-3.1M
ExitQ1 2026
$3M
$23.60
$27.74
Steven CohenPoint72
$14M590.9k shares
AddQ1 2026
$2M
$23.60
$27.74
Jim SimonsRenaissance Technologies
$10M441k shares
AddQ1 2026
$2M
$23.60
$27.74
Ken GriffinCitadel Advisors
$3.7M
AddQ4 2025
$4M
$29.47
$27.74

Congress Trades

NameValueActionAmount RangePriceLast Price
Gilbert CisnerosDemocrat
$8k
BuyMay 29, 2026
$1k-$15k
--
$27.74
Gilbert CisnerosDemocrat
$8k
BuyMar 3, 2026
$1k-$15k
--
$27.74
Gilbert CisnerosDemocrat
$8k
SellDec 11, 2025
$1k-$15k
--
$27.74

Insider Trades

NameValueActionPriceLast Price
Burnett PatrickSee Remarks
$4.7k222 shares
SellMay 11, 2026
$21.05
$27.74
Vairavan LathaSVP Chief Financial Officer
$9.2k435 shares
SellMay 11, 2026
$21.05
$27.74
Matsuda MasaruSee Remarks
$172k7.4k shares
SellMay 4, 2026
$23.27
$27.74
Watanabe ToddDirector, Officer: See Remarks
$75k3.2k shares
SellMay 4, 2026
$23.61
$27.74
Vairavan LathaSVP Chief Financial Officer
$32k1.3k shares
SellMay 4, 2026
$23.61
$27.74
Matsuda MasaruSee Remarks
$21k884 shares
SellMay 4, 2026
$23.61
$27.74

News

globenewswire.comArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 5globenewswire.comNew Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatologyglobenewswire.comJun 3globenewswire.comArcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conferenceglobenewswire.comMay 26seekingalpha.comArcutis Biotherapeutics: The Dermatology Platform Is Starting To Compoundseekingalpha.comMay 15globenewswire.comArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comMay 8